Sirolimus for systemic lupus erythematosus - Authors' reply.

Perl, Andras; Lai, Zhi-Wei; Kelly, Ryan; Faraone, Stephen V; Phillips, Paul E

Perl, Andras; Lai, Zhi-Wei; Kelly, Ryan; Faraone, Stephen V; Phillips, Paul E.

Afiliação

Perl A; Division of Rheumatology, State University of New York Upstate Medical University, Syracuse, NY 13210, USA; Department of Medicine, State University of New York Upstate Medical University, Syracuse, NY 13210, USA; Department of Microbiology, State University of New York Upstate Medical University, S
Lai ZW; Division of Rheumatology, State University of New York Upstate Medical University, Syracuse, NY 13210, USA; Department of Medicine, State University of New York Upstate Medical University, Syracuse, NY 13210, USA.
Kelly R; Division of Rheumatology, State University of New York Upstate Medical University, Syracuse, NY 13210, USA; Department of Medicine, State University of New York Upstate Medical University, Syracuse, NY 13210, USA.
Faraone SV; Department of Psychiatry, State University of New York Upstate Medical University, Syracuse, NY 13210, USA.
Phillips PE; Division of Rheumatology, State University of New York Upstate Medical University, Syracuse, NY 13210, USA; Department of Medicine, State University of New York Upstate Medical University, Syracuse, NY 13210, USA.

Lancet ; 392(10149): 734, 2018 09 01.

Article em En | MEDLINE | ID: mdl-30191826

Assuntos

Lúpus Eritematoso Sistêmico; Sirolimo; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sirolimo / Lúpus Eritematoso Sistêmico Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google